Jump to content

Robert C. Bast Jr.

From Wikipedia, the free encyclopedia
Robert C. Bast Jr.
Born(1943-12-08)December 8, 1943
Alma mater
Scientific career
InstitutionsUniversity of Texas MD Anderson Cancer Center
Website

Robert Clinton Bast Jr., (born December 8, 1943) is an American physician-scientist who is currently Vice President for Translational Research at the University of Texas M.D. Anderson Cancer Center.[1] Bast is best known for the discovery of CA125, a serum biomarker for ovarian cancer that has contributed to the care of ovarian cancer patients worldwide.[2] His research spans early detection, enhancing chemotherapy and understanding regulation of dormancy and the role of autophagy in breast and ovarian cancer.

References

[edit]
  1. ^ "Robert C. Bast". MD Anderson Cancer Center. Retrieved 2019-05-20.
  2. ^ "Robert C. Bast, Jr., M.D." NFCR. Retrieved 2019-05-20.